Nucera Carmelo相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Correction: SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2

更正：SCFβ-TRCP 通过促进 VEGF 受体 2 的泛素化和破坏来抑制血管生成和甲状腺癌细胞迁移。

期刊:Journal of Experimental Medicine

影响因子:10.6

doi:10.1084/jem.2011244608082025c

Shaik, Shavali; Nucera, Carmelo; Inuzuka, Hiroyuki; Gao, Daming; Garnaas, Maija; Frechette, Gregory; Harris, Lauren; Wan, Lixin; Fukushima, Hidefumi; Husain, Amjad; Nose, Vania; Fadda, Guido; Sadow, Peter M; Goessling, Wolfram; North, Trista; Lawler, Jack; Wei, Wenyi

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers

针对甲状腺癌中血管生成和免疫微环境之间通讯的治疗方法

期刊:Current Opinion in Endocrine and Metabolic Research

doi:10.1016/j.coemr.2024.100544

Prete, Alessandro; Nucera, Carmelo

免疫/内分泌

发表日期：2024

文献求助收藏

Case Report of CCDC149-ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma

CCDC149-ALK融合病例报告：转移性乳头状甲状腺癌中一种新的基因改变及临床相关靶点

影响因子:6.7

doi:10.1089/thy.2022.0389

Lee, Hannah; Krishnan, Vimal; Wirth, Lori J; Nucera, Carmelo; Venturina, Mariza; Sadow, Peter M; Mita, Alain; Sacks, Wendy

免疫/内分泌

发表日期：2022

文献求助收藏

Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAF(V600E) Papillary Thyroid Carcinoma

通过靶向线粒体相关乙酰辅酶A羧化酶2来微调BRAF(V600E)乳头状甲状腺癌中的脂质代谢

影响因子:6.7

doi:10.1089/thy.2020.0311

Valvo, Veronica; Iesato, Asumi; Kavanagh, Taylor R; Priolo, Carmen; Zsengeller, Zsuzsanna; Pontecorvi, Alfredo; Stillman, Isaac E; Burke, Suzanne D; Liu, Xiaowen; Nucera, Carmelo

免疫/内分泌

发表日期：2021

文献求助收藏

Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network Analysis

调控性非编码RNA在侵袭性甲状腺癌中的作用：神经网络分析的展望

期刊:Molecules

影响因子:4.6

doi:10.3390/molecules26103022

Iesato, Asumi; Nucera, Carmelo

免疫/内分泌

发表日期：2021

文献求助收藏

Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer

肿瘤微环境相关的周细胞群可能影响甲状腺癌的治疗反应

期刊:Advances in Experimental Medicine and Biology

doi:10.1007/978-3-030-73119-9_14

Iesato, Asumi; Nucera, Carmelo

细胞生物学

肿瘤微环境

免疫/内分泌

发表日期：2021

文献求助收藏

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment

更正：血小板反应蛋白-1沉默下调BRAF(V600E)突变型人间变性甲状腺癌细胞中整合素的表达水平：对宿主组织适应和肿瘤微环境稳态的新见解

期刊:Frontiers in Endocrinology

影响因子:4.6

doi:10.3389/fendo.2020.596223

Duquette, Mark; Sadow, Peter M; Lawler, Jack; Nucera, Carmelo

细胞生物学

肿瘤微环境

免疫/内分泌

发表日期：2020

文献求助收藏

Coding Molecular Determinants of Thyroid Cancer Development and Progression

甲状腺癌发生发展中分子决定因素的编码

期刊:Endocrinology and Metabolism Clinics of North America

影响因子:4.2

doi:10.1016/j.ecl.2018.10.003

Valvo, Veronica; Nucera, Carmelo

免疫/内分泌

发表日期：2019

文献求助收藏

A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer

一种新型的联合靶向疗法，采用溴结构域拮抗剂和MEK抑制剂治疗间变性甲状腺癌

期刊:Oncotarget

doi:10.18632/oncotarget.26591

Nucera, Carmelo

免疫/内分泌

发表日期：2019

文献求助收藏

Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFÎ²1 Axis.

周细胞通过 TSP-1/TGFβ1 轴诱导甲状腺癌对维莫非尼和索拉非尼治疗产生耐药性

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-18-0693

Prete Alessandro, Lo Agnes S, Sadow Peter M, Bhasin Swati S, Antonello Zeus A, Vodopivec Danica M, Ullas Soumya, Sims Jennifer N, Clohessy John, Dvorak Ann M, Sciuto Tracey, Bhasin Manoj, Murphy-Ullrich Joanne E, Lawler Jack, Karumanchi S Ananth, Nucera Carmelo

细胞生物学

发表日期：2018

文献求助收藏